![]() |
市场调查报告书
商品编码
1463757
欧洲凤梨蛋白酶市场预测至 2030 年 - 区域分析 - 按来源(茎和水果)和应用(食品和饮料、药品和保健品、个人护理等)Europe Bromelain Market Forecast to 2030 - Regional Analysis - by Source (Stem and Fruit) and Application (Food & Beverages, Pharmaceuticals & Nutraceuticals, Personal Care, and Others) |
2022年欧洲凤梨蛋白酶市场价值为1,172万美元,预计到2030年将达到2,079万美元;预计 2022 年至 2030 年CAGR为 7.4%。
製药和保健品行业应用的增加推动了欧洲凤梨蛋白酶市场
凤梨蛋白酶在製药工业中用作抗肿瘤、抗发炎和抗血栓形成剂。而且还能预防支气管炎、鼻窦炎、血栓性静脉炎等疾病。人们对其血小板聚集抑制、抗水肿、抗血栓和纤溶活性进行了研究。它也因其帮助消化和促进伤口癒合的能力而闻名。由于这些治疗作用,它被广泛用于药物配方和保健品。人们越来越关注保持最佳消化和肠道健康,这增加了膳食补充剂生产中对凤梨蛋白酶的需求。
凤梨蛋白酶也用于治疗受伤或手术后鼻子和鼻窦的发炎和肿胀。凤梨蛋白酶的抗发炎和镇痛特性使其能够有效治疗与骨关节炎相关的疼痛、软组织肿胀和关节僵硬。凤梨蛋白酶可改善功能并减轻轻微急性膝盖疼痛和骨关节炎的疼痛。根据世界卫生组织(WHO) 的数据,2019 年全球有近5.28 亿人患有骨关节炎,自1990 年以来增加了113%。了市场的成长。
欧洲菠萝蛋白酶市场概况
欧洲凤梨蛋白酶市场分为德国、法国、义大利、英国、俄罗斯和欧洲其他地区。欧洲市场的成长归因于凤梨蛋白酶在化妆品、膳食补充剂和其他应用中的接受度不断提高。食品和饮料行业生活方式趋势的转变进一步推动了该地区欧洲凤梨蛋白酶市场的成长。在烘焙业中,凤梨蛋白酶被用作麵团改良剂和风味增强剂。据英国麵包师联合会称,烘焙业是食品和饮料行业最大的细分市场之一。凤梨蛋白酶製造商正在开发新颖的产品,以满足食品和饮料行业日益增长的需求。例如,2021 年 8 月,比利时公司 ENZYBEL GROUP 推出了一款名为凤梨蛋白酶 K 的新凤梨蛋白酶产品,专为肉类嫩化、蛋白质水解剂和增味剂等食品和饮料应用而开发。
凤梨蛋白酶在德国和其他西欧国家被广泛用作保健补充剂,也用于治疗受伤或手术后鼻子和鼻窦的发炎和肿胀。此外,凤梨蛋白酶可以改善功能并减轻轻微急性膝痛和膝骨关节炎的疼痛。根据 Versus Arthritis 于 2023 年初发布的报告,欧洲有 1,000 万人患有骨关节炎,估计有 540 万人患有膝骨关节炎。骨科疾病的高发生率增加了对凤梨蛋白酶补充剂的需求。
欧洲拥有完善的个人护理行业,是化妆品和其他个人护理产品最重要的市场之一。以凤梨蛋白酶为基础的美容补充剂可增强皮肤强度和弹性,从而为皮肤提供抗皱效果。以凤梨蛋白酶为基础的护肤产品可改善干燥和受损皮肤的外观,并用于治疗痤疮。该地区金融状况的改善导致化妆品和个人护理产品的人均支出增加。根据个人护理品製造商协会Cosmetics Europe统计,2020年欧盟化妆品产业相关类别中,保养品的市场价值最为可观。
欧洲凤梨蛋白酶市场收入及2030年预测(千美元)
欧洲菠萝蛋白酶市场细分
欧洲凤梨蛋白酶市场分为来源、应用和国家。
从来源来看,欧洲凤梨蛋白酶市场分为茎和果。 2022 年,茎细分市场将占据更大份额。
从应用来看,欧洲凤梨蛋白酶市场分为食品和饮料、药品和保健品、个人护理等。 2022 年,食品和饮料领域占最大份额。
根据国家/地区,欧洲凤梨蛋白酶市场分为德国、法国、义大利、英国、俄罗斯和欧洲其他地区。 2022 年,欧洲其他地区主导了欧洲凤梨蛋白酶市场。
Challenge Bioproducts Co Ltd、Creative Enzymes、Enzybel International SA 和 Medikonda Nutrients 是欧洲凤梨蛋白酶市场上的一些领先公司。
表中的内容
The Europe bromelain market was valued at US$ 11.72 million in 2022 and is expected to reach US$ 20.79 million by 2030; it is estimated to grow at a CAGR of 7.4% from 2022 to 2030.
Increasing Applications in Pharmaceutical & Nutraceutical Industry Fuels the Europe Bromelain Market
Bromelain is used in the pharmaceutical industry as an anti-tumorigenic, anti-inflammatory, and anti-thrombotic agent. Moreover, it can prevent diseases such as bronchitis, sinusitis, and thrombophlebitis. It has been studied for its platelet aggregation inhibition, anti-edematous, anti-thrombotic, and fibrinolytic activities. It is also known for its ability to aid in digestion and wound-healing enhancement. Owing to these therapeutic actions, it is extensively used in pharmaceutical formulas and health supplements. The growing focus on maintaining optimum digestive and gut health boosts the demand for bromelain in dietary supplement manufacturing.
Bromelain is also applied in treating inflammation and swelling of the nose and sinuses after an injury or surgery. The anti-inflammatory and analgesic properties of bromelain make it an effective treatment for pain, soft tissue swelling, and joint stiffness associated with osteoarthritis. Bromelain improves functionality and decreases pain in mild acute knee pain and osteoarthritis. According to the World Health Organization (WHO), nearly 528 million people worldwide were living with osteoarthritis in 2019, recording an increase of 113% since 1990. Therefore, the rising applications of bromelain in the pharmaceutical & nutraceutical industries fuels the market growth.
Europe Bromelain Market Overview
The Europe bromelain market is segmented into Germany, France, Italy, the UK, Russia, and the Rest of Europe. The market growth in Europe is ascribed to the increasing acceptance of bromelain in cosmetics, dietary supplements, and other applications. Transforming lifestyle trends concerning the food & beverages industry further boosts the Europe bromelain market growth in the region. In the bakery industry, bromelain is used as a dough improver and flavor enhancer. According to the UK Federation of Bakers Ltd, the bakery industry is one of the largest segments in the food & beverages sector. Bromelain manufacturers are developing novel products to cater to the increasing demand from the food & beverages industry. For instance, in August 2021, ENZYBEL GROUP, a Belgium-based company, launched a new bromelain product called bromelain K, developed specifically for food & beverages applications such as meat tenderization, protein hydrolyzer, and flavor enhancer.
Bromelain is extensively used as a health supplement in Germany and other Western European countries and is also applied in treating inflammation and swelling of the nose and sinus after an injury or surgery. In addition, bromelain improves functionality and decreases pain in mild acute knee pain and knee osteoarthritis. According to a report by Versus Arthritis, published in early 2023, 10 million people in Europe have osteoarthritis, and 5.4 million people are estimated to have knee osteoarthritis. Such high incidences of orthopedic diseases boost the demand for bromelain-based supplements.
Europe has a well-established personal care industry, and it is one of the most prominent markets for cosmetics and other personal care products. Bromelain-based beauty supplements enhance skin strength and elasticity, thus providing an anti-wrinkle effect to the skin. Bromelain-based skincare products enhance the appearance of dry and damaged skin and are used to treat acne. The improving financial conditions across the region result in increased per capita expenditure on cosmetic and personal care products. According to Cosmetics Europe, an association of personal care product manufacturers, skincare had the most considerable market value among all the categories related to the cosmetics industry in the European Union in 2020. The growing demand for cosmetic products indicates the increasing need for bromelain in Europe.
Europe Bromelain Market Revenue and Forecast to 2030 (US$ Thousand)
Europe Bromelain Market Segmentation
The Europe bromelain market is segmented into source, application, and country.
Based on source, the Europe bromelain market is bifurcated stem and fruit. The stem market segment held a larger share in 2022.
In terms of application, the Europe bromelain market is categorized into food & beverages, pharmaceuticals & nutraceuticals, personal care, and others. The food & beverages segment held the largest share in 2022.
Based on country, the Europe bromelain market is segmented Germany, France, Italy, the UK, Russia, and the Rest of Europe. The Rest of the Europe dominated the Europe bromelain market in 2022.
Challenge Bioproducts Co Ltd, Creative Enzymes, Enzybel International SA, and Medikonda Nutrients are some of the leading companies operating in the Europe bromelain market.
Table of Content